Abstract. Brain trauma has been shown to be a risk factor for developing Alzheimer disease (AD), and AD-like plaques containing amyloid-␤ (A␤) peptides have been found in the brain shortly following trauma. Here, we evaluated the effects of brain trauma on the accumulation of A␤ and expression of amyloid precursor protein (APP) genes (APP695 and APP751/ 770) over 1 yr in a non-transgenic rodent model. Anesthetized male Sprague-Dawley rats were subjected to parasagittal fluid percussion brain injury of moderate severity (2.5-2.9 atm) or sham treatment and their brains were evaluated at 2, 4, 7, 14 days, and 1, 2, 6, 12 months following injury. Immunohistochemical analysis detected only weak A␤ staining by 2 wk following injury. However, by 1 month to 1 yr following injury, strong immunoreactivity for A␤ was found in damaged axons throughout the thalamus and white matter. Western blot analysis confirmed the accumulation of A␤ peptides in tissue from injured brains. Although in situ hybridization demonstrated an increased gene expression of APP751/770 surrounding the cortical lesion at 2 to 7 days following injury, this expression returned to baseline levels at all subsequent time points and no increase in the expression of APP695 was detected at any time point. These results demonstrate that long-term A␤ accumulation in damaged axons can be induced in a non-transgenic rodent model of brain trauma. Surprisingly, the extent of this A␤ production appeared to be dependent on the maturity of the injury, but uncoupled from the gene expression of APP. Together, these data suggest a mechanism that may contribute to long-term neurodegeneration following brain trauma.
INTRODUCTION
There are now a series of compelling studies that demonstrate a link between traumatic brain injury (TBI) and Alzheimer disease (AD). Several large epidemiological examinations have revealed that TBI is an epigenetic risk factor for developing AD (1) (2) (3) (4) . In addition, hallmark pathologic features of AD, diffuse plaques composed of amyloid-␤ (A␤) peptides, and neurofibrillary tangles have been found in the brains of boxers displaying demential pugilistica (''punch-drunk syndrome'') (5, 6) . Subsequently, diffuse A␤ plaques were found within days of a single incident of brain trauma in humans (7) (8) (9) . However, the link between TBI and AD is not without controversy. Some epidemiological studies have failed to find a statistical relationship between TBI and AD (10) (11) (12) (13) , and in one report, A␤ plaques could not be identified in the brains of TBI patients shortly following a single injury (14) . Following brain trauma in humans and animal models, amyloid precursor protein (APP), which is cleaved to form A␤ peptides, has been found to accumulate in high concentration in damaged axons (15) (16) (17) (18) . However, it has only recently been observed that A␤ also accumulates in the terminal swellings of disconnected axons following brain trauma in a model of inertial brain injury in the pig (19) . These axonal A␤ accumulations were found in association with A␤ plaque-like profiles in the white and gray matter. Accordingly, proteolytic cleavage of accumulating APP in damaged axons may be an important source for post-traumatic deposition of A␤. However, potential long-term progressive changes in traumatized axons that might lead to the development of AD and other neurodegenerative disease processes have not been previously examined.
In the present study, we used an experimental model of parasagittal fluid percussion (FP) brain injury in the rat to explore the temporal course of A␤ accumulation in axons over 1 yr following injury. In addition, we evaluated potential long-term changes in the gene expression of 2 forms of APP following injury. This rat model has previously been shown to induce long-term neurodegenerative changes, including substantially progressive brain tissue atrophy, neuron loss, and axonal degeneration (20) . Although A␤ accumulation has not previously been observed in non-transgenic rodent models of brain trauma despite several efforts (15, 16, 18) , we postulated that improved immunohistochemical reagents and potential age-dependent factors would facilitate detection.
MATERIALS AND METHODS
This study was conducted in accordance with the animal welfare guidelines set forth in Guide for the Care and Use of Laboratory Animals, U.S. Department of Health and Human Services Publication No. 1985 . All animal procedures were
Parasagittal FP Brain Injury
Male Sprague-Dawley rats (Harlan, Indianapolis, IN), 3 to 4 months old (350-400 g), were subjected to lateral FP brain injury (n ϭ 78) or sham injury (n ϭ 42) (21) . The animals were anesthetized with sodium pentobarbital (60 mg/kg, i.p.) and mounted in a stereotactic frame. The scalp and left temporal muscle were reflected and a 5-mm craniotomy was performed, centered between lambda and bregma over the left parietal cortex, with the dura remaining intact at this site. A plastic, female Luer-Lok fitting (internal diameter, 3.5 mm) was set in the craniotomy site and held in place with dental cement. Ninety minutes (min) after anesthesia administration, 78 animals received FP injury. The FP device used is a Plexiglas cylinder filled with saline, closed at one end by a male Luer-Lok fitting that can be paired with the female Luer-Lok affixed to the animal. To induce injury, a pendulum was allowed to strike a plunger at one end of the FP device cylinder, causing a rapid, high-pressure injection of saline into the closed cranial cavity of the animal attached to the other end of the cylinder. A pressure transducer measured the force of the injury, and these data were recorded using Enhanced Graphics Acquisition Analysis Software (RC Electronics, Golea, CA). Injury was produced at a peak force of 2.5 to 2.9 atm with total pulse duration of 20 to 23 msec. Sham (control) animals received identical treatment without FP injury. Extensive physiologic monitoring was not performed in the present study since several previously published reports failed to identify a substantial physiologic response using the identical injury paradigm. In the previous studies, only modest and very transient changes were found in brain temperature (temporalis muscle), mean arterial pressure, pulse, electroencephalography, and brainstem evoked potential (21) (22) (23) (24) . Brain blood flow has also been found to be only modestly and transiently reduced in most brain areas following injury and does not even reach ischemic thresholds near the impact site (25) .
Tissue Preparation
For immunohistochemical analyses, a first group of animals was anesthetized with lethal injections of sodium pentobarbital (200 mg/kg, i.p.) at 1 wk, 2 wk, 1 month, 2 months, 6 months, and 1 yr after lateral FP brain injury or sham treatment (n ϭ 5 injured; n ϭ 3 sham at each time point), and were perfused transcardially with heparinized saline for 1 to 2 min. The brains were removed and fixed by immersion in 70% ethanol in 150 mM NaCl. Coronally sectioned blocks (3-5-mm-thick) were then processed for paraffin embedding. Serial sections (6 m) were cut on a Leitz rotary microtome (Leica, Malvern, PA) and mounted on poly-L-lysine coated slides. For immunoblot and immunoprecipitation analyses, a second group of animals was deeply anesthetized and perfused with heparinized saline at 1 wk, 1 month, 6 months, and 1 yr following FP brain injury or sham treatment (n ϭ 5 injured; n ϭ 3 sham at each time point). Following perfusion, the cerebral cortex, hippocampus, and thalamus were quickly dissected from 3-mm-thick coronal slices. Protein was individually extracted from each tissue block using lysis buffer, centrifuged, and the supernatant and pellet separately frozen at Ϫ80ЊC. For in situ hybridization, a third group of animals was deeply anesthetized and decapitated at 2 and 4 days, 1 and 2 wk, 1 and 6 months, and 1 yr after FP injury (n ϭ 4 for each time point). Sham animals were killed at 2 days, 1, 6 months, and 1 yr after sham treatment (n ϭ 3 for each time point). The brains were removed, frozen on crushed dry ice, and stored at Ϫ80ЊC. Coronal 10-m-thick sections were cut on a cryostat at Ϫ20ЊC, thaw-mounted on poly-L-lysine coated slides, and processed for in situ hybridization.
Immunohistochemistry
The 6-m sections were blocked with 5% H 2 O 2 in methanol for 30 min and 2% normal horse serum (NHS) in 0.1M Tris PH 7.4 for 30 min and then incubated overnight with a monoclonal antibody (mAb) or a polyclonal antibody (pAb) to A␤ peptides, APPs, and neurofilament proteins. The highly specific and well-characterized antibodies used to detect A␤ proteins included mouse mAb 6E10 specific for A␤1-17 at 1:200 (Signet, Dedham, MA), rabbit pAb 2332 specific for A␤1-17 at 1: 4,000 (a gift from Dr. V. M.-Y. Lee), mouse mAb 4G8 specific for A␤17-24 at 1:1,000 (Signet), mouse mAb BA27 specific for A␤1-40 (Wako Chemicals USA, Richmond, VA), mouse mAb BCO5 specific for A␤1-42 (Wako Chemicals USA), and rabbit pAb 13335 specific for A␤1-42 at 1:1,000 (a gift from Dr. V. M.-Y. Lee). The antibodies used to detect APP proteins included goat pAb Karen specific for APP/N-terminal at 1:800, rabbit pAb 369W specific for APP645-694 at 1:1,000, rabbit pAb Ln39 specific for APP 1-100 at 1:20 (gifts from Dr V. M-Y Lee), and mouse mAb 22C11 specific for APP/N-terminal at 1:40 (Chemicon International, Temecula, CA). Antibodies used to detect neurofilament (NF) proteins included a mouse mAb NR4 specific for the NF68 at 1:400 (Sigma, St. Louis, MO) and a mouse mAb N52 specific for NF200 at 1:400 (Sigma). Sections were then rinsed 3 ϫ 10 min with 0.1 M Tris, incubated with biotinylated antibody, and avidin biotin-peroxides (Vector Laboratories, Burlingame, CA), and DAB (Vector Laboratories) for visualization. Negative controls for immunohistochemistry were tissue sections from the same brains, which were treated in the same manner except the primary antibody incubation was omitted.
Double Immunohistochemistry
To detect colocalization of A␤ with NF, A␤ with APP in injured axons, sections were incubated with a rabbit pAb 13335 (A␤1-42) at 1:1,000 in 2% normal goat serum (NGS) in 0.1 M Tris at 4ЊC overnight. On the following day, the sections were washed 3 ϫ 10 min with 0.1 M Tris and then incubated in fluorescein isothiocyanate (FITC) conjugated goat anti-rabbit antibody (Jackson ImmunoResearch, West Grove, PA) for 1 hour (h). Sections were then washed 3 ϫ 10 min with 0.1 M Tris, after which they were blocked with 2% NGS for 30 min and incubated with a mouse anti-NF200 mAb (N52) at 1:400 or a mouse anti-APP/N-terminal mAb (22C11) for at 1:40 overnight at 4ЊC. On the following day, sections were washed 3 ϫ 10 min with 0.1 M Tris, after which were reincubated with Texas red-conjugated goat anti-mouse antibody at 1:200 for 1 h.
To detect A␤ accumulation in neural cells, sections were stained with a rabbit pAb A␤ 13335 antibody at 1:1,000, then stained with a mouse mAb anti-neuronal nuclei (Chemicon International) at 1:100. The immunohistochemistry processing was described as above.
Semiquantitative Analysis for Immunohistochemistry
In all animals used for immunohistochemical evaluation, a semiquantitative determination of the number of axonal profiles was performed using an MCID Imaging Research image analysis system (Imaging Research, Inc., St. Catharines, Canada). The groups of animals killed at the various time points following injury or sham treatment were completely randomized and analyzed by observers that were blinded to the identity or injury status of individual animals. Axonal profiles (darkly immunoreactive varicose axonal swellings and axonal bulbs) were identified by their immunoreactivity and distinct morphology, and were counted manually using light microscopy at ϫ100 magnification in the coronal brain section. For each stain, 5 sections were examined at the level of Ϫ3.6 mm Bregma. The mean number of axonal profiles for each animal was determined, and plotted on spatio-temporal maps of coronal brain sections.
Immunoprecipitation for A␤
Tissue was washed twice in PBS and lysed in a 3-fold volume of RIPA buffer (1ϫ PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS) with a cocktail of protease inhibitor (Roche Diagnostics, Indianapolis, IN). After homogenization with Dounce hand homogenizer, tissue lysates were centrifuged at 100,000 g for 30 min at 4ЊC. The supernatant and pellet were separately frozen at Ϫ80ЊC. The protein concentration was determined by DC protein assay (Bio-Rad, Hercules, CA) according to the manufacturer's instructions. For immunoprecipitation of A␤, 750 l (1 g/l) of individual samples was incubated with 1.0 g normal horse IgG (Sigma) and 20 l protein A/G PLUS-Agarose (Santa Cruz Biotechnology, Santa Cruz, CA) for 30 min at 4ЊC. After a spin of 1,000 g for 5 min at 4ЊC, the proteins in supernatant were precipitated with 20 l of a rabbit pAb 13335 specific for A␤1-42 and 20 l of protein A/G PLUS-Agarose at 4ЊC overnight. The pellets were collected by centrifugation at 1,000 g for 5 min at 4ЊC and then washed 4 times with RIPA buffer (PBS containing 1% NP-40, 0.1% SDS, 0.02% sodium azide), each time repeating centrifugation step as above. The samples were boiled for 5 min following resuspension of the pellet in 30 l of 2ϫ SDS sample buffer (glycerol 1 ml, ␤-mercaptoethanol 0.5 ml, 10% SDS 3 ml, 1.0 M Tris-HCI 1.25 ml, pH 6.7, and bromophenol blue 2 mg). A␤ was separated by high performance 12% Bis/Tris NuPAGE Gel (Invitrogen, Carlsbad, CA). The gel was electrotransferred to immunobilon membrane (Millipore, Bedford, MA) for Western blot analysis.
Western Blot Analysis
Tissue preparation and protein extraction were described as above. The samples were boiled in SDS sample buffer for 5 min and run on 20% poly-acrylamide gel or Bis/Tris NuPage gel. The protein in the gel was electrotransferred to immunobilon membrane. Non-specific binding was blocked by 5% nonfat milk in PBST (9.1 mM Dibasic sodium phosphate, 1.7 mM monobasic sodium phosphate, 150 mM NaCl, and 0.1% Tween 20) for 30 min at room temperature. A␤ was determined by primary antibodies to pAb 13335 specific for A␤1-42 at 1: 2,000 (for immunoblot and immunoprecipitation) and mAb 4G8 specific for A␤17-24 at 1:1,000 (for immunoblot) overnight at 4ЊC, and then by biotinylated secondary antibodies (diluted to 1:500-1:1,000, Vector Laboratories) as well as Vectastain ABC kit (diluted 1:1,000, Vector Laboratories) for 1 h each at room temperature. Before the products were visualized by DAB (Vector Laboratories) the membranes were washed 3 times with TTBS (100 mM Tris, 0.9% NaCl, and 0.1% Tween 20) once for 5 min at room temperature.
In Situ Hybridization for APP Expression
In situ hybridization (ISH) was performed using oligonucleotide probes. The probe sequences were as follows: APP695 (40 mer, 5Ј-GCT GGC TGC CGT CGT GGG AAC TCG GAC TAC CTC CTC CAC A-3Ј) (26); APP751/770 (40 mer, 5Ј-CTT GAG TAA ACT TTG GGA TGA CAC GCT GCC ACA CAC CGC C-3Ј) (26) . The oligonucleotide probe was labeled for ISH with [␣- 35 S]deoxyadenosine triphosphate (dATP) (NEN, Boston, MA) at the 3Ј end using terminal deoxynucleotidyl transferase (Roche Diagnostics). The specific activity of the labeled probes was 0.5-1.0 ϫ 10 9 cpm/g. The general ISH techniques used in this study have been described previously in detail (27) . Briefly, slide-mounted sections were fixed in 4% formaldehyde in 0.1 M phosphate buffer (pH 7.2) for 60 min, rinsed 2 times (5 min each) in 4ϫ sodium saline citrate solution (SSC) (pH 7.2; NaCl 35 g/l, sodium citrate 17.6 g/l), and dehydrated through a graded ethanol series (70%-100%). The sections were subsequently lipidized with chloroform for 6 min, and immersed twice in 100% ethanol for 3 min before rehydration. Hybridization was performed by incubating the sections with a buffer containing 4ϫ SSC, 50% deionized formamide, 0.12 M phosphate buffer (pH 7.2), 1ϫ Denhardt's solution, 2.5% transfer ribonucleic acid, and [ 35 S]dATP-labeled probes (0.5-1.0ϫ 106 cpm/slide, 200 l/ slide) for 16 h at 42Њ C. After the hybridization, the sections were rinsed in 1ϫ SSC (pH 7.2) for 10 min at room temperature, followed by 4 rinses in 1ϫ SSC at 55ЊC for 15 min. The sections were dehydrated through a graded ethanol series (70-100%). Kodak (Rochester, NY) XAR film was placed on the uncoated sections for 5 days and developed. The slides were coated with Kodak NT-2 emulsion diluted with water (1:1). The slides were exposed for 3 to 4 wk in a tightly sealed dark box at 4ЊC, developed in Kodak D-19, fixed, stained with thionin, and coverslipped. The specificities of oligonucleotide probes were verified by control hybridization experiments using ribonuclease (RNase) treatment (10 mg/ml) prior to hybridization, or adding the unlabeled probe in excess (100-fold) to the hybridization buffer. No significant signals above background were detected in the sections processed after RNase treatment, or with a mixture of labeled and excess unlabeled probes.
Quantification of Macroautoradiogram Density and
Staining Intensity on Immunoblotting APP mRNA expression was measured on the macroautoradiograms by determining the optical density (NIH image) of sections taken at the level of the cingulate cortex, 2.8-mm to 3.3-mm posterior from bregma. value of the densities was used for further analysis. Optical density ratio (ODR) of the lesion side versus the contralateral side was calculated. All values are presented as the means Ϯ SE. Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by the Fisher test for multiple comparison. A p value less than 0.05 was considered significant.
The expression of A␤ protein was measured by determining the staining intensities on digital pictures of the membrane using NIH image software. Statistical analysis was performed as above.
RESULTS

General Response to Injury
Immediately after FP injury all animals had apnea for 15 to 60 s. Five percent of animals had mild tremor-like activity of the upper extremities for 3 to 5 s. However, no overt signs of seizure activity were noted thereafter. All animals in this study recovered quickly from injury and were ambulatory within 1 h following trauma. Within a few hours post-injury, all animals displayed normal grooming and eating behavior. All animals were periodically weighed and no differences were noted between injured and non-injured groups throughout the 1-yr analysis. Although the injured animals appeared generally normal, we have previously observed that mild neurologic motor dysfunction and moderate cognitive deficits persist for up to 1 yr following FP injury (28) .
Gross Examination
In sham animals, no pathological changes were found at any time course. As previously noted (20) , progressive atrophy and neurodegeneration were observed following brain trauma. Gross observation of injured brains revealed the cortical cavity of the left parietotemporal cortex at 1 month after lateral FP injury, which clearly expanded further by 2 months post-injury. Communication between the cortical cavity and ventricle at the level of the dorsal hippocampus occurred by approximately 6 months to 1 yr following injury in all cases. The ipsilateral cortical, hippocampal, thalamic, and septal regions progressively diminished in size over the course of 1 yr following brain trauma. The calcification in the thalamus was observed from 2 months forward. 
Axonal Pathology and A␤ Accumulation
In the sham animals, no axonal injury was found at any time point. Consistent with previous observations (20, 28, 29) , axonal bulb formation and axonal swellings kDa neurofilament proteins elucidated damaged axons in the cortex surrounding the cortical cavity, subcortical white matter, hippocampus and thalamus. There was evidence of ongoing axonal damage in various brain regions from 2 wk to 1 yr after brain trauma (Fig. 1) .
Using specific antibodies to A␤ ( Fig. 2A, F Fig. 2A-D) , while no A␤ immunoreactivity was found in sham animals at any time point (Fig. 2E) . However, strong A␤ immunoreactivity was not found until the protracted time point of 1 month following injury. We also observed limited A␤ immunoreactivity detected by 2332/A␤1-17 antibody in degenerating fragments, ipsilateral to the injury site in the thalamus of injured animals at 1 month to 1 yr post-injury near axonal bulbs (Fig. 2F, G) , suggesting that A␤ was released from damaged axons into the brain parenchyma.
Although fewer in total number of profiles, the distribution of A␤ immunoreactivity in axonal bulbs generally followed that of APP, appearing in the subcortex surrounding the cortical cavity, with greater numbers in thalamus, as schematically demonstrated in Figure 3 . Additionally, while axonal pathology was found at all time points examined, there appeared to be a slight decrease in the total extent of reactive axonal changes over 1 yr following injury (Fig. 3) .
From 1 month to 1 yr following brain injury, double fluorescence immunohistochemistry demonstrated the colocalization (Fig. 4C, F, I ) of APP detected by 22C11 antibody (Fig. 4A, D, G) with A␤ detected by 13335 antibody (Fig. 4B , E, H) in the axonal bulbs (Fig. 4A -F) at 6 months ( Fig. 4D-F) to 1 yr (Fig. 4A-C) postinjury, while the accumulation of APP (Fig. 4G) without A␤ (Fig. 4H ) was found in connected swollen axons (Fig.  4G-I ) at 2 months (Fig. 4G-I ) post-injury. The double fluorescence immunohistochemistry also demonstrated the colocalization (Fig. 4L, O) of NF200 detected by N52 antibody (Fig. 4J, M) with A␤ detected by 13335 antibody (Fig. 4K , N) at 6 months ( Fig. 4M-O) to 1 yr (Fig.  4J-L) post-injury. A␤ accumulation was also found in hippocampal (Fig. 4P-R ) and cortical neurons (Fig. 4S-U) shown by colocalization (Fig. 4R, U) of NeuN (Fig.  4P, S) with A␤ (Fig. 4Q, T) at 2 months post-injury. Although NF protein and APP immunoreactivity was observed in both the terminal ends of disconnected axons and in axonal swellings of non-disconnected axons, A␤ immunoreactivity was predominantly restricted to disconnected axonal bulbs and was not typically found in axonal swellings of non-disconnected axons (Fig. 4G-I) .
Expression of A␤ for Immunoblot and Immunoprecipitation
In corroboration of immunohistochemical identification of A␤ production and accumulation in injured brains, immunoblot analysis identified A␤ in injured brains, but not in sham brains. We found expression of A␤ in ipsilateral (injured) hemisphere from 1 wk to 1 yr following TBI. On immunoblots, anti-A␤ antibodies (Fig. 5A : 4G8/ A␤17-24; Fig. 5B , C: 13335/A␤1-42) illuminated with a band on with a molecular weight 4 kDa, consistent with A␤. The staining intensities on digital pictures of immunoblots were measured using NIH image software and significantly increased at 1 wk, 1 month, 6 months, and 1 yr following injury, compared to the tissue of agematched sham groups (p Ͻ 0.05). We consistently found that the expression of A␤ in the brain tissue samples appeared to follow the same temporal pattern as was found with immunohistochemical analysis.
Long-Term APP Gene Expression
In sham-operated animals, autoradiography showed expression of APP695 mRNA in the cortical neurons, dentate gyrus, pyramidal cell layers in hippocampus, and thalamus (Fig. 6) . In injured animals, the expression of APP695 mRNA significantly decreased in the cortical lesion at 2 days to 1 yr following trauma (p Ͻ 0.001) (Figs. 6, 7) in the same regions as neuronal cell death and tissue loss. The expression of APP695 mRNA decreased in the ipsilateral thalamus at 2 days to 1 yr following trauma also in the same regions of cell death (Figs. 6, 7) . Not shown is 1-yr data that was virtually the same as the mRNA expression profiles found at 6 months.
In sham-operated animals, the expression of APP751/ 770 mRNA was very slightly evident in hippocampus (Fig. 6) . In injured animals, the expression of APP751/ 770 mRNA significantly increased in and around the cortical lesion and bilateral hippocampus at 2 days to 1 wk following trauma (p Ͻ 0.001) (Figs. 6, 7) . In addition, the expression of APP751/770 mRNA significantly increased in the ipsilateral thalamus at 1 wk following trauma (p Ͻ 0.05). However, this expression returned and remained at baseline levels at all time points up to 1 yr following injury (Figs. 6, 7) . Not shown is 1-yr data that was virtually the same as the mRNA expression profiles found at 6 months.
DISCUSSION
Here, we found accumulation of APP and its cleavage product, A␤, in swollen, disconnected axons for up to 1 yr following brain trauma in a non-transgenic rodent. The immunohistochemical identification of A␤ accumulation was corroborated by Western blot analysis of tissue samples. Surprisingly, substantial A␤ accumulation in damaged axons was not found until protracted post-injury time points of 1 month and longer. This observation suggests that proteolytic processing of accumulated APP may change over time following trauma. Furthermore, in contrast to previous assumptions, long-term APP and A␤ accumulation after brain trauma was not accompanied by a persistent increase in APP mRNA expression, demonstrating that overexpression of APP is not necessary for increased A␤ accumulation following brain trauma.
Axonal injury is one of the most common and important pathologic features of brain trauma (30, 31) . It is widely believed that axonal swelling and disconnection is a limited event following injury, persisting for no more than a few months (32, 33) . However, we have previously shown that white matter loss due to axonal pathology is a progressive process that persists for at least 1 yr following brain trauma in the rat, a period extending over half of the lifespan of this species (20, 28, 29) . This progressive axonal loss in the rat was found to be most overt in the white matter tracts of injured subcortex and in the thalamus. Likewise, brain atrophy in humans is commonly observed following trauma and has been reported to most notably affect the white matter (34, 35) . Thus, the process of long-term progressive axonal pathology observed in animal models of brain trauma may also occur in human TBI patients. However, definitive studies have yet to be undertaken.
It remains unclear why axons disconnect and degenerate after such a protracted time following trauma in animal models. Possible mechanisms include delayed neuron death with deafferentation. In addition, axons damaged at the time of brain trauma may continue to function relatively normally until they are exposed to an additional stress, such as post-traumatic progressive inflammatory changes (29) . Regardless of the mechanism, progressive axonal damage may contribute to ongoing neurodegenerative processes. In particular, lysis of the terminal swollen bulb of disconnected axons may serve as a vehicle for the release of potentially toxic proteins, peptides, and their aggregates into the brain parenchyma.
One of these potential toxins is A␤. In the present study, strong A␤ staining was found in swollen axons by 1 month and persisted for at least 1 yr following brain trauma. This A␤ colocalized with APP and NF proteins in disconnected axonal bulbs. The events leading to this co-accumulation were likely initiated by interruption of axonal transport due to delayed failure of the axonal cytoskeleton (36) . Subsequently, the accumulating pool of APP may have provided ample substrate for A␤ production. Although APP also accumulated in swollen axons that appeared to be still connected, A␤ was not typically detected in these profiles. These data support our hypothesis that delayed disconnection of axons, or ''secondary axotomy'' induces a unique intra-axonal proteolytic milieu that favors the production and accumulation of A␤ in axonal bulbs (19) . Nonetheless, our current data also demonstrates that axonal disconnection represents only part of the process leading to A␤ formation in axons following brain trauma. Within days following brain injury, we found a high concentration of disconnected axonal bulbs filled with APP, but very few of these profiles also demonstrated accumulation of A␤. Only by 1 month following trauma was substantial accumulation of A␤ found in axonal bulbs and in tissue homogenates. This finding may represent the first evidence that brain trauma can initiate pathologic cascades that become progressively more pronounced over protracted periods of weeks to months. For example, delayed A␤ formation following brain trauma might be related with a glial cytokine-mediated cascade as previously reported in AD (37) .
In the present study, we did not find any overt differences between A␤1-40 and A␤1-42 accumulation based on immunoreactivity to antibodies specific for these 2 A␤ peptides. Notably, however, A␤1-42 appears to be the predominant A␤ peptide in the early stage of AD and the acute stage of head injury (38, 39) .
Another pathologic change also found to have a delayed appearance was the accumulation of A␤ in neurons in the injured cortex and hippocampus from 6 months and 1 yr following brain trauma in rats. However, no ADlike A␤ plaques were found at any post-injury time point. This may reflect differences in processing or in the amino acid sequence of A␤ in non-transgenic rodents compared to humans, as has been previously suggested (15) .
Although we found no direct evidence in the present study that A␤ produced following trauma was toxic, we have previously suggested a potential ''2 hit'' phenomenon, whereby A␤ may potentiate damage when combined with brain injury (40) . Inducing brain trauma in transgenic mice that overexpress mutant human APP and eventually develop A␤ plaques (41), massive neuron death was found in hippocampus in association with a marked increases in soluble A␤ peptide levels (40) . This observation may have clinical implications since large increases in A␤ peptides in the cerebrospinal fluid have been found in brain-injured patients (42, 43) . Our current observation of a prolonged production of A␤ initiated by brain trauma suggests a potential role of A␤ in the progressive neurodegenerative changes of neuron death and tissue atrophy found in several rodent brain injury models.
A surprising finding in the present study was the absence of relationship between APP mRNA expression and the persistent accumulation of APP and A␤. Three types of APP mRNA, produced by alternative splicing, have been detected by Northern blotting in human and rat brains (44) (45) (46) . These mRNAs encode APP695 lacking or APP751/770 containing a Kunitz protease inhibitory (KPI) domain that may contribute to an increase in A␤ formation (46, 47) . In AD patients, brain mRNA (46, (48) (49) (50) (51) (52) (53) (54) (55) (56) and protein levels for KPI ϩ APP751/770 are elevated (26, (57) (58) (59) (60) (61) . In addition, in animal models, selective elevation of mRNA for KPI ϩ APP751/770 has been found following ischemia, neurotoxic damage, and seizures and traumatic brain injury (26, (57) (58) (59) (60) (61) . However, long-term changes in APP mRNA expression have not previously been examined in these models.
Similar to a previous report of APP mRNA expression following brain trauma in rats (61) , in this study we found that the expression of APP751/770 mRNA increased around the cortical lesion shortly following injury. However, this increase lasted only 7 days following brain trauma and subsequently returned to normal levels at all later time points evaluated up to 1 yr post-injury. Although persistent ''decreases'' in the expression of APP695 and APP751/770 mRNA were found, it seems clear that these changes simply reflected cell death and tissue loss. These results demonstrate that long-term APP and A␤ accumulation following brain trauma may occur without persistent elevations of mRNA for KPI ϩ APP. These findings are potentially in contrast with studies of transgenic mice, where only overexpression of KPI ϩ APP mRNA has been shown to induce persistent A␤ production (40, 62, 63) .
In summary, the results from the present study provide evidence that persistent A␤ production and or accumulation, 1) can be detected in a non-transgenic rodent model of brain trauma, 2) occurs primarily in damaged axons, 3) becomes more pronounced with maturation of the injury, and 4) is uncoupled from the mRNA expression of APP. Together, these data suggest that brain trauma may induce long-term neurodegenerative processes similar to those found in AD.
